BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36628908)

  • 1. Facility volume and survival: Human papilloma virus positive oropharyngeal squamous cell carcinoma.
    Patel R; Didzbalis CJ; Tseng CC; Talmor G; Park RCW
    Am J Otolaryngol; 2023; 44(2):103762. PubMed ID: 36628908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Papillomavirus Impact on Temporal Treatment Trends in Oropharyngeal Carcinoma: 2010-2016.
    Amin N; Thompson J; Goloubeva O; Witek M; Taylor RJ; Wolf JS; Moyer K; Mehra R; Hatten KM
    ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):438-446. PubMed ID: 36067748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Treatment Parameters on Racial Survival Differences in Oropharyngeal Cancer: National Cancer Database Study.
    Zhu D; Wong A; Oh EJ; Ahn S; Wotman M; Sahai T; Bottalico D; Frank D; Tham T
    Otolaryngol Head Neck Surg; 2022 Jun; 166(6):1134-1143. PubMed ID: 34399637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
    Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
    Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
    Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
    JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of second primary malignancies after transoral surgery in human papilloma virus-positive oropharyngeal squamous cell carcinoma.
    Stepan K; Craig E; Skillington SA; Deutsch BC; Chen S; Wamkpah NS; Bollig CA; Kallogjeri D; Thorstad WL; Puram SV; Pipkorn P; Jackson RS
    Head Neck; 2022 May; 44(5):1069-1078. PubMed ID: 35175648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Human Papilloma Virus and Lifestyle Factors in Overall Survival of Patients with Oropharyngeal Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Kitahara T; Hasegawa Y
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical analysis of oropharyngeal squamous cell carcinoma: a single-institution's experience.
    Jiromaru R; Yasumatsu R; Yamamoto H; Kuga R; Hongo T; Nakano T; Manako T; Hashimoto K; Wakasaki T; Matsuo M; Nakagawa T
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3717-3725. PubMed ID: 34978590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment trends for advanced oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Mirza FA; Johnson CZ; Byrd JK; Albergotti WG
    Head Neck; 2021 Nov; 43(11):3476-3492. PubMed ID: 34499392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives.
    Khoo A; Boyer M; Jafri Z; Makeham T; Pham T; Khachigian LM; Floros P; Dowling E; Fedder K; Shonka D; Garneau J; O'Meara CH
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic Factors Influence the Impact of Tumor HPV Status on Outcome of Patients With Oropharyngeal Squamous Cell Carcinoma.
    Marks JA; Switchenko JM; Steuer CE; Ryan M; Patel MR; McDonald MW; Higgins K; Beitler JJ; Shin DM; Gillespie TW; Saba NF
    JCO Oncol Pract; 2021 Mar; 17(3):e313-e322. PubMed ID: 33434083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Lymph Node Yield on Survival in Surgically Treated Oropharyngeal Squamous Cell Carcinoma.
    Gomez ED; Chang JC; Ceremsak JJ; Brody RM; Brant JA; Rassekh CH; Weinstein GS; Newman JG
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):146-156. PubMed ID: 32689888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Hospital Safety-Net Burden Status on Patients with HPV-Positive Oropharyngeal Cancer.
    Gilja S; Kumar A; Kapustin D; Su V; Rubin SJ; Chai R; Roof SA; Khan MN
    Laryngoscope; 2024 Apr; 134(4):1733-1740. PubMed ID: 37933810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Nodal Metastases in HPV-Negative Oropharyngeal Cancer.
    Chang CM; Chen MM; Bellile EL; Rozek LS; Carey TE; Spector ME; Wolf GT; Taylor JM; Chinn SB
    Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1554-1563. PubMed ID: 35579907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Shiao JC; Holt D; Ladbury C; Gao D; Jones B; Karam SD; Amini A
    Oral Oncol; 2022 Jul; 130():105907. PubMed ID: 35605559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.
    Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D
    Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.
    Husain S; Lohia S; Petkov V; Blackwell T; Swisher-McClure S; Mizrachi A; Morris LG; Cohen MA; Wong RJ; Roman BR
    Head Neck; 2021 Jul; 43(7):2110-2123. PubMed ID: 33851469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.